DEXCOM, INC. Impairment of Intangible Assets, Finite-lived
DEXCOM, INC. (DXCM) reported Impairment of Intangible Assets, Finite-lived of $1.30 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2017-02-28
- DEXCOM, INC. impairment of intangible assets, finite-lived for fiscal 2016 was $1.30M.
- DEXCOM, INC. impairment of intangible assets, finite-lived for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- DEXCOM, INC. impairment of intangible assets, finite-lived for fiscal 2014 was $200.00K.
- DEXCOM, INC. impairment of intangible assets, finite-lived for fiscal 2013 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|
| 2016-12-31 | $1.30M 10-K · filed 2017-02-28 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-28 |
| 2014-12-31 | $200.00K 10-K · filed 2017-02-28 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-25 |
| 2012-12-31 | $0.00 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |